HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PAK 200

structure given in first source; reverses in vivo resistance of tumor cells to adriamycin
Also Known As:
2-(benzyl(phenyl)amino)ethyl-1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1-(2-morpholinoethyl)-4-(3-nitrophenyl)-3-pyridine carboxylate; PAK-200; PAK-200S; 3-Pyridinecarboxylic acid, 5-(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-1-(2-(4-morpholinyl)ethyl)-4-(3-nitrophenyl)-, 2-(phenyl(phenylmethyl)amino)ethyl ester, P-oxide, dihydrochloride
Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Ohno, Nobuhito: 1 article (04/2002)
2. Akiyama, Shin-ichi: 1 article (04/2002)
3. Furukawa, Tatsuhiko: 1 article (04/2002)
4. Saito, Takeshi: 1 article (04/2002)
5. Kreitman, Robert J: 1 article (04/2002)
6. Sumizawa, Tomoyuki: 1 article (04/2002)
7. Arima, Terukatsu: 1 article (04/2002)
8. Masamoto, Izumi: 1 article (04/2002)
9. Hanada, Shuichi: 1 article (04/2002)
10. Takeuchi, Shogo: 1 article (04/2002)

Related Diseases

1. Neoplasms (Cancer)
2. T-Cell Leukemia (Leukemia, T Cell)
3. Colorectal Neoplasms (Colorectal Cancer)
4. Leukemia

Related Drugs and Biologics

1. 1,4-dihydropyridine (dihydropyridine)
2. P-Glycoprotein
3. Topotecan (Hycamtin)
4. Cyclosporine (Ciclosporin)
5. Tacrolimus (Prograf)
6. Vincristine (Oncovin)
7. Quinidine (Chinidin)
8. Doxorubicin (Adriamycin)
9. Immunotoxins (Immunotoxin)
10. cepharanthine